Published in Exp Biol Med (Maywood) on March 02, 2016
Sickle cell disease severity: an introduction. Exp Biol Med (Maywood) (2016) 0.75
Transient red cell aplasia in two brothers with sickle cell anemia and erythrovirus B19 infection. Rev Bras Hematol Hemoter (2016) 0.75
Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia. N Engl J Med (1995) 13.59
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG). Lancet (2011) 7.30
Parvovirus B19. N Engl J Med (2004) 6.83
Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. JAMA (2014) 5.01
Outbreak of aplastic crises in sickle cell anaemia associated with parvovirus-like agent. Lancet (1981) 4.62
Definitions of the phenotypic manifestations of sickle cell disease. Am J Hematol (2010) 2.55
Hydroxyurea enhances fetal hemoglobin production in sickle cell anemia. J Clin Invest (1984) 2.43
Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children. Pediatrics (2008) 2.42
Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr (1992) 2.02
The prevalence of antibody to human parvovirus B19 in England and Wales. J Med Microbiol (1988) 1.80
Human parvovirus infection in homozygous sickle cell disease. Lancet (1993) 1.71
Impact of hydroxyurea on clinical events in the BABY HUG trial. Blood (2012) 1.66
Occurrence of infection with a parvovirus-like agent in children with sickle cell anaemia during a two-year period. J Clin Pathol (1982) 1.43
Advances in the use of hydroxyurea. Hematology Am Soc Hematol Educ Program (2009) 1.40
Epidemiology of human parvovirus B19 in children with sickle cell disease. Blood (2003) 1.40
Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis (2006) 1.09
Erythropoietic activity in patients with sickle cell anaemia before and after treatment with hydroxyurea. Br J Haematol (1999) 0.95
Simultaneous acute splenic sequestration and transient aplastic crisis in children with sickle cell disease. Pediatr Blood Cancer (2009) 0.91
Immunologic effects of hydroxyurea in sickle cell anemia. Pediatrics (2014) 0.89
Subclinical parvovirus B19 infection in children with sickle cell anemia. J Pediatr Hematol Oncol (2003) 0.88
Fatal bone marrow embolism in a child with hemoglobin SE disease. Am J Hematol (2010) 0.87
Human serum parvovirus as the cause of aplastic crisis in sickle cell disease. Am J Dis Child (1984) 0.85
Seroprevalence of human parvovirus B19 in a suburban population in São Paulo, Brazil. Rev Saude Publica (2008) 0.80
Immune parameter analysis of children with sickle cell disease on hydroxycarbamide or chronic transfusion therapy. Br J Haematol (2015) 0.80
Study of chronic hemolytic anaemia patients in Rio de Janeiro: prevalence of anti-human parvovirus B19 IgG antibodies and the development aplastic crises. Rev Inst Med Trop Sao Paulo (2002) 0.79
Transient aplastic crisis in patients with sickle cell disease. B19 parvovirus studies during a 7-year period. Am J Dis Child (1992) 0.78
Profound sustained reticulocytopenia and anaemia in an adult patient with sickle cell disease. Transfus Med (2014) 0.78
Acute human parvovirus B19 infection and nephrotic syndrome in patients with sickle cell disease. Br J Haematol (2010) 0.77
Life threatening parvovirus B19 and herpes simplex virus associated acute myocardial dysfunction in a child with homozygous sickle cell disease. Pediatr Blood Cancer (2007) 0.77
Aplastic crisis due to extensive bone marrow necrosis and human parvovirus infection in sickle cell disease. Am J Med (1991) 0.77
Vitamin A deficient mice exhibit increased viral antigens and enhanced cytokine/chemokine production in nasal tissues following respiratory virus infection despite the presence of FoxP3+ T cells. Int Immunol (2015) 0.78
Extended Matrix and Inverse Matrix Methods Utilizing Internal Validation Data When Both Disease and Exposure Status Are Misclassified. Epidemiol Method (2013) 0.77
The immune correlates of protection for an avian influenza H5N1 vaccine in the ferret model using oil-in-water adjuvants. Sci Rep (2017) 0.75
Prevnar-13 vaccine failure in a mouse model for vitamin A deficiency. Vaccine (2017) 0.75